|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Prednisolone. Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (690)
Cases resulting in a serious event (687)
Cases resulting in death (178)
Cases resulting in life threatening events (82)
Cases resulting in hospitalization (314)
Cases resulting in disability (32)
Cases resulting in other serious reactions (351)
Below is a sample of reports where side effects / adverse reactions may be related to Prednisolone. For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 62 year old female receiving Prednisolone
Reported by a individual with unspecified qualification from Japan on 2007-10-31
Patient: 62 year old female
Adverse reactions / side effects: Bronchopulmonary Aspergillosis, Cardiac Failure, Fungus Serology Test Positive
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Azathioprine
Administration route: Oral
Indication: Systemic Lupus Erythematosus
Neoral
Administration route: Oral
Indication: Systemic Lupus Erythematosus
Prednisolone
Administration route: Oral
Indication: Systemic Lupus Erythematosus
Adverse event in 7 year old female receiving Prednisolone
Reported by a consumer/non-health professional from Greece on 2007-10-31
Patient: 7 year old female, weighing 25.0 kg (55.0 pounds)
Adverse reactions / side effects: Erythema Infectiosum, Histiocytosis Haematophagic
Adverse event resulted in: death
Suspect drug(s):
Azathioprine
Indication: Diffuse Vasculitis
Start date: 2001-08-01
Cyclophosphamide
Indication: Diffuse Vasculitis
Start date: 2007-04-27
End date: 2007-04-27
Cyclosporine
Indication: Diffuse Vasculitis
Start date: 2007-05-02
End date: 2007-05-04
Etanercept
Indication: Diffuse Vasculitis
Start date: 2001-08-01
Kineret
Indication: Diffuse Vasculitis
Start date: 2006-03-22
End date: 2007-04-20
Methotrexate
Indication: Diffuse Vasculitis
Start date: 2001-08-01
Methylprednisolone
Indication: Diffuse Vasculitis
Start date: 2007-05-03
End date: 2007-05-05
Prednisolone
Administration route: Oral
Indication: Diffuse Vasculitis
Start date: 2001-06-20
End date: 2002-05-15
Other drugs received by patient: Corticosteroid
Adverse event in 34 year old male receiving Prednisolone
Reported by a physician from United Kingdom on 2007-10-31
Patient: 34 year old male
Adverse reactions / side effects: C-Reactive Protein Increased, Pyrexia, Abdominal Pain Upper, Abdominal Tenderness, Gallbladder Perforation
Adverse event resulted in: hospitalization
Suspect drug(s):
Prednisolone
Adverse event in 7 year old female receiving Prednisolone
Reported by a physician from Greece on 2007-10-30
Patient: 7 year old female, weighing 25.0 kg (55.0 pounds)
Adverse reactions / side effects: Parvovirus Infection, Histiocytosis Haematophagic, Drug Interaction, Immunosuppression
Adverse event resulted in: death
Suspect drug(s):
Azathioprine
Indication: Drug USE FOR Unknown Indication
Cyclophosphamide
Dosage: 800 mg iv
Indication: Drug USE FOR Unknown Indication
Start date: 2007-04-27
End date: 2007-04-27
Cyclosporine
Indication: Drug USE FOR Unknown Indication
Start date: 2007-05-02
End date: 2007-05-04
Entanercept
Indication: Drug USE FOR Unknown Indication
Kineret
Dosage: 25 mg/kg once sc
Indication: Vasculitis
Start date: 2006-03-22
End date: 2007-04-20
Methotrexate
Indication: Drug USE FOR Unknown Indication
Methylprednisolone
Dosage: 300 mg/kg iv
Indication: Drug USE FOR Unknown Indication
Start date: 2007-05-03
End date: 2007-05-05
Prednisolone
Indication: Drug USE FOR Unknown Indication
Start date: 2001-06-21
End date: 2002-05-15
Adverse event in 16 year old female receiving Prednisolone
Reported by a physician from Japan on 2007-10-30
Patient: 16 year old female
Adverse reactions / side effects: Spinal Compression Fracture, Diabetes Mellitus, Autoimmune Hepatitis, Hepatic Vein Stenosis, Generalised Oedema, Liver Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Medrol
Administration route: Oral
End date: 2006-01-27
Medrol
Administration route: Oral
Start date: 2007-03-07
End date: 2007-04-04
Medrol
Administration route: Oral
Start date: 2007-04-18
End date: 2007-06-23
Mycophenolate Mofetil
Administration route: Oral
Start date: 2006-01-01
Mycophenolate Mofetil
Administration route: Oral
Start date: 2006-01-27
End date: 2006-01-30
Mycophenolate Mofetil
Administration route: Oral
Start date: 2006-01-31
End date: 2006-01-31
Mycophenolate Mofetil
Administration route: Oral
Start date: 2006-02-01
End date: 2006-04-27
Mycophenolate Mofetil
Administration route: Oral
Start date: 2006-04-28
Mycophenolate Mofetil
Administration route: Oral
End date: 2007-03-11
Mycophenolate Mofetil
Administration route: Oral
Start date: 2007-03-12
End date: 2007-03-13
Mycophenolate Mofetil
Administration route: Oral
Start date: 2007-03-14
End date: 2007-03-24
Mycophenolate Mofetil
Administration route: Oral
Start date: 2007-03-25
End date: 2007-03-27
Mycophenolate Mofetil
Administration route: Oral
Start date: 2007-03-28
End date: 2007-03-28
Mycophenolate Mofetil
Administration route: Oral
Start date: 2007-04-04
End date: 2007-04-04
Mycophenolate Mofetil
Administration route: Oral
Start date: 2007-04-05
Prednisolone
Administration route: Oral
Start date: 2007-06-24
Solu-Medrol
Dosage: note: 40 ~ 1000 mg
Indication: Liver Transplant Rejection
Start date: 2007-04-04
End date: 2007-04-17
Other drugs received by patient: Prograf; Neoral; Actonel; Lasix
Adverse event in 85 year old female receiving Prednisolone
Reported by a individual with unspecified qualification from Norway on 2007-10-29
Patient: 85 year old female
Adverse reactions / side effects: Tachycardia, Tricuspid Valve Incompetence, C-Reactive Protein Increased, Dyspepsia, Blood Creatinine Increased, White Blood Cell Count Increased, Anuria, Hiatus Hernia, Diastolic Dysfunction, Renal Cyst, Computerised Tomogram Abnormal, Organ Failure, Haemoglobin Decreased, Hepatic Cyst, Cardiac Failure, Mitral Valve Incompetence, Ejection Fraction Decreased, Peptic Ulcer Perforation
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Ibux
Indication: Myalgia
Prednisolone
Dosage: 10 mg/day
Indication: Myalgia
Voltaren
Indication: Myalgia
Other drugs received by patient: Zantac
Adverse event in 34 year old male receiving Prednisolone
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-26
Patient: 34 year old male
Adverse reactions / side effects: Gallbladder Perforation
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Prednisolone
Adverse event in 43 year old male receiving Prednisolone
Reported by a individual with unspecified qualification from United Kingdom on 2007-10-26
Patient: 43 year old male
Adverse reactions / side effects: Osteonecrosis, Spinal Fracture, Osteoporosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclophosphamide
Dosage: text:6df
Indication: Burkitt's Lymphoma
Start date: 1998-01-01
End date: 1998-09-01
Cytarabine
Indication: Burkitt's Lymphoma
Doxorubicin Hydrochloride
Dosage: text:6df
Indication: Burkitt's Lymphoma
Start date: 1998-04-01
End date: 1998-09-01
Hydrocortisone Acetate
Administration route: Oral
Indication: Burkitt's Lymphoma
Start date: 1998-04-01
End date: 1998-09-01
Methotrexate
Indication: Burkitt's Lymphoma
Start date: 1998-01-01
End date: 1998-09-01
Prednisolone
Administration route: Oral
Indication: Burkitt's Lymphoma
Start date: 1998-04-01
End date: 1998-09-01
Ritonavir
Dosage: daily dose:800mg
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Saquinavir
Dosage: daily dose:800mg
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1998-04-01
Sulfamethoxazole
Trimethoprim
Administration route: Oral
Indication: Pneumocystis Jiroveci Infection
Vincristine
Dosage: text:6df-freq:1 cyclical
Indication: Burkitt's Lymphoma
Start date: 1998-04-01
End date: 1998-09-01
Other drugs received by patient: CO-Trimoxazole
Adverse event in 42 year old male receiving Prednisolone
Reported by a physician from Australia on 2007-10-26
Patient: 42 year old male
Adverse reactions / side effects: Megakaryocytes Increased, Thrombocytopenia, Idiopathic Thrombocytopenic Purpura
Suspect drug(s):
Cyclosporine
Mycophenolate Mofetil
Prednisolone
Adverse event in female receiving Prednisolone
Reported by a physician from Japan on 2007-10-25
Patient: female
Adverse reactions / side effects: Pneumocystis Jiroveci Pneumonia
Adverse event resulted in: hospitalization
Suspect drug(s):
Bonalon
Administration route: Oral
Indication: Osteoporosis
Foliamin
Administration route: Oral
Indication: Prophylaxis
Prednisolone
Administration route: Oral
Prednisolone
Administration route: Oral
Indication: Rheumatoid Arthritis
Prograf
Administration route: Oral
Indication: Rheumatoid Arthritis
Remicade
Remicade
Dosage: 5 infusions
Remicade
Indication: Rheumatoid Arthritis
Rheumatrex
Administration route: Oral
Indication: Rheumatoid Arthritis
Voltaren
Administration route: Oral
Indication: Rheumatoid Arthritis
Adverse event in 54 year old female receiving Prednisolone
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-24
Patient: 54 year old female
Adverse reactions / side effects: CD4 Lymphocytes Decreased, Blast Crisis in Myelogenous Leukaemia, Nuchal Rigidity, Headache, Cerebral Toxoplasmosis, CSF Protein Increased, Pneumonia Bacterial, CSF White Blood Cell Count Increased, Pseudomonal Sepsis
Adverse event resulted in: death
Suspect drug(s):
Cyclosporine
Indication: Stem Cell Transplant
Start date: 2005-12-01
Cyclosporine
Dosage: 150 mg/day
Cyclosporine
Dosage: 75 mg/day
Prednisolone
Dosage: 2 mg/kg/day
Indication: Acute Graft Versus Host Disease in Liver
Prednisolone
Dosage: 0.2 mg/kg/day
Sulfamethoxazole and Trimethoprim
Indication: Stem Cell Transplant
Adverse event in 51 year old female receiving Prednisolone
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-24
Patient: 51 year old female
Adverse reactions / side effects: Sepsis, Blood Pressure Decreased, White Blood Cell Count Increased
Adverse event resulted in: life threatening event
Suspect drug(s):
Immucyst
Indication: Carcinoma in Situ of Bladder
Start date: 2006-10-23
End date: 2006-11-06
Prednisolone
Administration route: Oral
Adverse event in 3 year old female receiving Prednisolone
Reported by a health professional (non-physician/pharmacist) from Denmark on 2007-10-24
Patient: 3 year old female
Adverse reactions / side effects: Systemic Candida, Oesophageal Stenosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Doxorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Prednisolone
Indication: Acute Lymphocytic Leukaemia
Vincristine Sulfate
Indication: Acute Lymphocytic Leukaemia
Adverse event in 66 year old female receiving Prednisolone
Reported by a individual with unspecified qualification from Japan on 2007-10-24
Patient: 66 year old female
Adverse reactions / side effects: Cytomegalovirus Antibody Positive, Visual Acuity Reduced, CD4 / CD8 Ratio Decreased, Herpes Zoster, Eye Haemorrhage, Sensation of Foreign Body, Haematocrit Decreased, Viral DNA Test Positive, RED Blood Cell Count Decreased, Bone Marrow Failure, CD8 Lymphocytes Decreased, Retinal Degeneration, Cataract, CD4 Lymphocytes Decreased, Conjunctival Oedema, Anaemia, Immunodeficiency, Haemoglobin Decreased, Cytomegalovirus Chorioretinitis, Brain Abscess, Retinal Exudates, Pneumonia Escherichia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Cyclosporine
Dosage: unk, unk
Administration route: Oral
Indication: Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis
Cyclosporine
Dosage: 75 mg/d
Administration route: Oral
Start date: 2005-06-01
Prednisolone
Dosage: 22.5 mg/d
Administration route: Oral
Indication: Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis
Start date: 2005-06-01
Prednisolone
Dosage: 60 mg/d
Administration route: Oral
Start date: 2004-12-01
Prednisolone
Dosage: 25 mg/d
Administration route: Oral
Other drugs received by patient: Endoxan; Warfarin Sodium; Denosine
Adverse event in 3 year old female receiving Prednisolone
Reported by a individual with unspecified qualification on 2007-10-23
Patient: 3 year old female
Adverse reactions / side effects: Pericarditis Fungal, Interstitial Lung Disease, Oral Candidiasis, Neutropenia, Candidiasis, Oesophageal Stenosis
Suspect drug(s):
Doxorubicin HCL
Indication: B Precursor Type Acute Leukaemia
Start date: 2005-11-06
Methotrexate
Indication: B Precursor Type Acute Leukaemia
Start date: 2005-11-06
Prednisolone
Indication: B Precursor Type Acute Leukaemia
Start date: 2005-11-06
Vincristine
Indication: B Precursor Type Acute Leukaemia
Start date: 2005-11-06
Other drugs received by patient: Miconazole; Tazobactam; Gentamicin; Fluconazole; Fluconazole; Ceftazidim; Vancomycin; Metronidazole; Acyclovir; Erythromycin; Bactrim; Ambisome; Voriconazole; Voriconazole
Adverse event in 7 year old female receiving Prednisolone
Reported by a physician from United States on 2007-10-23
Patient: 7 year old female, weighing 25.0 kg (55.0 pounds)
Adverse reactions / side effects: Parvovirus Infection, Histiocytosis Haematophagic, Immunosuppression
Adverse event resulted in: death
Suspect drug(s):
Azathioprine
Indication: Drug USE FOR Unknown Indication
Cyclophosphamide
Indication: Drug USE FOR Unknown Indication
Start date: 2007-04-27
End date: 2007-04-27
Etanercept
Indication: Drug USE FOR Unknown Indication
Gengraf Oral Solution
Indication: Drug USE FOR Unknown Indication
Start date: 2007-05-02
End date: 2007-05-04
Kineret
Indication: Vasculitis
Start date: 2007-04-14
End date: 2007-04-20
Methotrexate
Indication: Drug USE FOR Unknown Indication
Methylprednisolone
Indication: Drug USE FOR Unknown Indication
Start date: 2007-05-03
End date: 2007-05-05
Prednisolone
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2001-06-20
End date: 2002-05-15
Adverse event in 58 year old female receiving Prednisolone
Reported by a consumer/non-health professional from United States on 2007-10-23
Patient: 58 year old female
Adverse reactions / side effects: Vomiting, Dyspnoea, Nausea, Atrial Fibrillation, Gastric Ulcer, Cardiac Failure, Chest Pain, Pleural Effusion, Melaena, Ulcer Haemorrhage
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Kineret
Indication: Rheumatoid Arthritis
Start date: 2003-04-01
End date: 2003-05-01
Prednisolone
Voltaren
Indication: Rheumatoid Arthritis
Other drugs received by patient: Methotrexate; Plasmapheresis; Hydroxychloroquine Sulfate; Metoprolol Succinate; Furosemide; Levothyroxine Sodium; Esomeprazole Magnesium
Adverse event in male receiving Prednisolone
Reported by a consumer/non-health professional from United Kingdom on 2007-10-23
Patient: male
Adverse reactions / side effects: Death
Adverse event resulted in: death
Suspect drug(s):
Acetaminophen
Dosage: 4000 mg, qd
Indication: Pain
Start date: 2007-08-08
Acetaminophen
Dosage: 1000 mg, prn
Administration route: Oral
Start date: 2007-08-08
End date: 2007-08-08
Bevacizumab
Dosage: 450 mg, q2w
Indication: Gastric Cancer
Start date: 2007-06-13
Duragesic-100
Dosage: 125 a?g, qd
Indication: Pain
Start date: 2007-08-01
Duragesic-100
Dosage: 100 a?g, qd
Start date: 2007-06-13
End date: 2007-08-01
Duragesic-100
Dosage: 75 a?g, qd
Start date: 2007-06-07
End date: 2007-06-13
Duragesic-100
Dosage: 50 a?g, qd
End date: 2007-06-07
Erlotinib
Dosage: 150 mg, qd
Administration route: Oral
Indication: Gastric Cancer
Start date: 2007-06-13
Gabapentin
Dosage: 900 mg, qd
Administration route: Oral
Indication: Pain
Start date: 2007-08-08
End date: 2007-08-13
Gabapentin
Dosage: 1800 mg, qd
Administration route: Oral
End date: 2007-08-08
Imodium
Dosage: 1 mg, prn
Administration route: Oral
Indication: Diarrhoea
Start date: 2007-06-27
Metadon
Dosage: 90 mg, qd
Administration route: Oral
Indication: Pain
Morphine
Dosage: 30 mg, prn
Administration route: Oral
Indication: Pain
Prednisolone
Dosage: 25 mg, qd
Administration route: Oral
Indication: Nausea
Start date: 2007-07-10
Supplement NOS
Administration route: Oral
Indication: Weight Decreased
Start date: 2007-06-27
Adverse event in male receiving Prednisolone
Reported by a physician from Japan on 2007-10-22
Patient: male, weighing 63.0 kg (138.6 pounds)
Adverse reactions / side effects: Hepatic Neoplasm Malignant, Disseminated Intravascular Coagulation, Small Cell Lung Cancer Extensive Stage
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Methotrexate
Administration route: Oral
Methotrexate
Administration route: Oral
Methotrexate
Administration route: Oral
Methotrexate
Administration route: Oral
Indication: Rheumatoid Arthritis
Prednisolone
Administration route: Oral
Prednisolone
Administration route: Oral
Indication: Rheumatoid Arthritis
Remicade
Remicade
Remicade
Dosage: 10 infusions (infusions 7-16) on unspecified dates.
Remicade
Remicade
Remicade
Remicade
Remicade
Remicade
Indication: Rheumatoid Arthritis
Other drugs received by patient: Adrenal Hormone Preparation; Mucosta; Mucosta; Adalat
Adverse event in 38 year old male receiving Prednisolone
Reported by a physician from China on 2007-10-19
Patient: 38 year old male
Adverse reactions / side effects: Erythema Infectiosum, Reticulocytosis, Aplasia Pure RED Cell, Normochromic Normocytic Anaemia, Reticulocytopenia
Suspect drug(s):
Mycophenolate Mofetil
Indication: Liver Transplant
Prednisolone
Indication: Liver Transplant
Tacrolimus
Indication: Liver Transplant
Other drugs received by patient: Cyclosporin A Formulation Unknown
Adverse event in 60 year old female receiving Prednisolone
Reported by a physician from United Kingdom on 2007-10-19
Patient: 60 year old female
Adverse reactions / side effects: Systemic Lupus Erythematosus
Suspect drug(s):
Prednisolone
Zetia
Administration route: Oral
Adverse event in 3 year old female receiving Prednisolone
Reported by a health professional (non-physician/pharmacist) from Denmark on 2007-10-19
Patient: 3 year old female
Adverse reactions / side effects: Candidiasis, Oesophageal Stenosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Doxorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Prednisolone
Indication: Acute Lymphocytic Leukaemia
Vincristine Sulfate
Indication: Acute Lymphocytic Leukaemia
Adverse event in male receiving Prednisolone
Reported by a consumer/non-health professional from Sweden on 2007-10-19
Patient: male, weighing 83.5 kg (183.7 pounds)
Adverse reactions / side effects: Polyomavirus-Associated Nephropathy
Adverse event resulted in: hospitalization
Suspect drug(s):
Mycophenolate Mofetil
Dosage: 500 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2006-12-16
End date: 2007-07-03
Mycophenolate Mofetil
Dosage: 250 mg, bid
Start date: 2007-07-05
Prednisolone
Dosage: 5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2006-12-17
Rituximab
Dosage: 800 mg, single
Indication: Renal Transplant
Start date: 2006-12-16
End date: 2006-12-16
Tacrolimus
Dosage: 2.5 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2006-12-16
End date: 2007-07-03
Tacrolimus
Dosage: 2 mg, bid
Start date: 2007-06-08
Other drugs received by patient: Furosemide; Metoprolol; Felodipine; Enalapril Maleate; Candesartan Cilexetil; Pantoprazole Sodium; Epoetin; Paracetamol; Zolpidem Tartrate
Adverse event in 39 year old male receiving Prednisolone
Reported by a physician from Australia on 2007-10-19
Patient: 39 year old male
Adverse reactions / side effects: Performance Status Decreased, Hepatic Function Abnormal, Pyrexia, Disease Progression, Stem Cell Transplant, Colonic Polyp, Ileus, Pseudomonal Sepsis, Acute Graft Versus Host Disease in Skin, Hepatosplenomegaly, Lethargy, Renal Failure Acute, Blood Lactate Dehydrogenase Increased, General Physical Health Deterioration, Pancytopenia, Staphylococcal Sepsis, Respiratory Distress, Mucosal Inflammation, Diarrhoea, Respiratory Failure, Blood Lactate Dehydrogenase Decreased, Lung Infiltration, T-Cell Lymphoma Recurrent
Adverse event resulted in: death
Suspect drug(s):
Cyclosporine
Indication: Stem Cell Transplant
Etanercept(etanercept) Formul
Methylprednisolone
Mycophenolate Mofetil
Prednisolone
Indication: Stem Cell Transplant
Prograf
Indication: Stem Cell Transplant
Adverse event in 7 year old female receiving Prednisolone
Reported by a consumer/non-health professional from Greece on 2007-10-19
Patient: 7 year old female, weighing 25.0 kg (55.0 pounds)
Adverse reactions / side effects: Erythema Infectiosum, Histiocytosis Haematophagic, Immunosuppression
Adverse event resulted in: death
Suspect drug(s):
Azathioprine
Indication: Diffuse Vasculitis
Start date: 2001-08-01
Cyclophosphamide
Indication: Diffuse Vasculitis
Start date: 2007-04-27
End date: 2007-04-27
Cyclosporine
Indication: Diffuse Vasculitis
Start date: 2007-05-02
End date: 2007-05-04
Etanercept
Indication: Diffuse Vasculitis
Start date: 2001-08-01
Kineret
Indication: Diffuse Vasculitis
Start date: 2006-03-22
End date: 2007-04-20
Methotrexate
Indication: Diffuse Vasculitis
Start date: 2001-08-01
Methylprednisolone
Indication: Diffuse Vasculitis
Start date: 2007-05-03
End date: 2007-05-05
Prednisolone
Administration route: Oral
Indication: Diffuse Vasculitis
Start date: 2001-06-20
End date: 2002-05-15
Other drugs received by patient: Corticosteroid
|
